NCT06691737

Brief Summary

The goal of this clinical trial is to assess the effect of whole body vibration (WBV) on postural stability, flexibility of the lumbar-pelvic-hip complex and lower leg muscles, and jumping ability in basketball players aged 9-15 years. The main questions it aims to answer are: Does WBV affect the level of postural stability in basketball players aged 9-15 years? Does WBV affect the level of postural stability in basketball players aged 9-15 years? Does WBV affect the flexibility of the iliopsoas, rectus femoris, posterior group of hamstrings, soleus and gastrocnemius in basketball players aged 9-15 years? Does WBV affect the jump height, relative peak power, contraction time in basketball players aged 9-15 years? Participants will take part in 6 vibration sessions at 20Hz over 6 weeks. Vibration will be performed on the Galileo Med35 platform (3x3 min).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 15, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

January 20, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 4, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 4, 2025

Completed
Last Updated

November 15, 2024

Status Verified

November 1, 2024

Enrollment Period

5 months

First QC Date

November 8, 2024

Last Update Submit

November 14, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Changes in Postural Stability

    Postural stability was measured as the overall stability index (OSI) on the Biodex Balance System on the stable and unstable platform with open and closed eyes.

    6 weeks before the intervention, the day before the intervention began, the day after the intervention, and 6 weeks after the intervention.

  • Range of motion (ROM) of the ankle, knee, and hip joints.

    Range of motion (ROM) of the ankle, knee, and hip joints, will be measured in a resting position using an inclinometer for the iliopsoas, rectus femoris, posterior hamstring, soleus, and gastrocnemius muscles separately.

    6 weeks before the intervention, the day before the intervention began, the day after the intervention, and 6 weeks after the intervention.

  • Countermovement Jump Performance

    Countermovement jump performance will be measured by using force plates, It will be assessed Jump height (JH), relative peak power (RPP), and contraction time (CT).

    6 weeks before the intervention, the day before the intervention began, the day after the intervention, and 6 weeks after the intervention.

Study Arms (2)

Generalized Joint Hypermobility

EXPERIMENTAL
Other: Whole Body Vibration

Not Generalized Joint Hypermobility

EXPERIMENTAL
Other: Whole Body Vibration

Interventions

Whole body vibration consists of 3-minute vibrations with a 30-second break. Participants were asked to step onto the platform barefoot and position their feet "3" from the center of the platform, with feet pointing forward, knees slightly bent, and upper limbs along the body. The training was divided into two parts: week 1 with a frequency of 20 Hz, and a constant amplitude of 3 mm.

Generalized Joint HypermobilityNot Generalized Joint Hypermobility

Eligibility Criteria

Age9 Years - 15 Years
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Men aged 9-15
  • Playing basketball in a sports club at least 2 training sessions a week

You may not qualify if:

  • Thrombosis (acute narrowing of blood vessels),
  • Inflammation of the musculoskeletal system,
  • Arthropathy,
  • Hernias,
  • Discopathies,
  • Tendonitis,
  • Fresh fractures,
  • Scars,
  • Surgeries,
  • Kidney stones,
  • Rheumatoid arthritis,
  • Implants in the body,
  • Epilepsy,
  • Current injuries to the musculoskeletal system,
  • Occurrence of chronic pain complaints of the musculoskeletal system.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 8, 2024

First Posted

November 15, 2024

Study Start

January 20, 2025

Primary Completion

June 4, 2025

Study Completion

June 4, 2025

Last Updated

November 15, 2024

Record last verified: 2024-11